Page 39 - 202013
P. 39

柴胡疏肝散辅助治疗重度抑郁症的网络药理学研究                                                         Δ


                                                                 3 #
              1*
                                3
                                        1
                                                1
        卢 玲 ,庄 胜 ,陈 炜 ,玉 倩 ,汪顺贵 ,李华霞 ,刁丽梅 (1.广西中医药大学研究生院,南宁 530001;
                                                         1
                        2
        2.广西医科大学生物医药协同创新中心,南宁 530021;3.广西中医药大学第一附属医院脑病科一区,南宁
        530023)
        中图分类号 R285          文献标志码 A          文章编号 1001-0408(2020)13-1569-06
        DOI  10.6039/j.issn.1001-0408.2020.13.06
        摘  要   目的:研究柴胡疏肝散辅助治疗重度抑郁症(MDD)的潜在分子机制。方法:采用网络药理学方法。利用基因表达综合
        数据库(GEO)下载MDD患者基因芯片数据集GSE76826,再利用R语言软件中的limma包筛选出MDD患者样本中的差异基因。
        利用中药系统药理学数据库和分析平台(TCMSP)筛选柴胡疏肝散的活性成分及其对应的靶标。通过在线软件 venny 2.1.0 对
        MDD的差异基因和柴胡疏肝散的靶标取交集,获取柴胡疏肝散治疗MDD的共同靶标基因,然后将共同靶标基因导入Cytoscape
        3.6.1软件构建“柴胡疏肝散活性成分-MDD靶标基因”关系网络。利用BisoGenet插件构建蛋白互作(PPI)网络,并对其进行拓扑
        结构分析,筛选核心靶标基因,进行京都基因与基因组百科全书(KEGG)通路分析。结果:柴胡疏肝散治疗 MDD 的活性成分有
        139种,包括槲皮素、山柰酚、木犀草素、豆甾醇等;其作用的核心靶点基因共有8个,包括NR3C2、DPP4、ALOX5、GSTM1、CCND1、
        IGFBP3等;其主要通过调节细胞受体、嘌呤代谢、类固醇生物合成、氨酰生物合成等信号通路发挥治疗MDD的作用。结论:柴胡
        疏肝散可通过多个靶标、多个途径发挥辅助治疗MDD的作用,可为后续研究其作用机制提供理论基础。
        关键词    网络药理学;柴胡疏肝散;重度抑郁症;靶标;机制
        Study on Chaihu Shugan Powder in the Adjunctive Treatment of Major Depressive Disorder Based on
        Network Pharmacology
        LU Ling ,ZHUANG Sheng ,CHEN Wei ,YU Qian ,WANG Shungui ,LI Huaxia ,DIAO Limei(1. Graduate
                                                                                  1
                                                                                               3
                                                                       1
                                                       1
                1
                                 2
                                             3
        School, Guangxi University of TCM, Nanning 530001, China; 2.Collaborative Innovation Center for
        Biomedicine, Guangxi Medical University, Nanning 530021, China; 3. Division 1 of Encephalopathy
        Department,the First Affiliated Hospital of Guangxi University of TCM,Nanning 530023,China)
        ABSTRACT    OBJECTIVE:To explore the molecular mechanism of Chaihu shugan powder in the adjunctive treatment of major
        depressive disorder(MDD). METHODS:Network pharmacology was adopted. The microarray dataset GSE76826 was downloaded
        from GEO common database,and the limma package was used to screen the differently expressed genes in the samples of MDD
        patients. The active ingredients and corresponding targets of Chaihu shugan powder were screened out based on TCMSP platform.
        Through the online software venny 2.1.0,the differently expressed genes of MDD and the targets of Chaihu shugan powder were
        screened,and the common target genes of Chaihu shugan powder for MDD were obtained. The target genes were introduced into
        Cytoscape 3.6.1 software to construct the network diagram of“Chaihu shugan powder active ingredients-MDD target gene”. Then,
        BisoGenet plug-in was used to construct the PPI network,analyze the topological structure and screen the core target gene. KEGG
        pathway analysis was conducted. RESULTS:There were 139 active components of Chaihu shugan powder for the treatment of
        MDD,including quercetin,kaempferol,luteolin,stigmasterol,etc. There were 8 core target genes,including NR3C2,DPP4,
        ALOX5,GSTM1,CCND1,IGFBP3 and so on. They play an important role in the treatment of MDD via signaling pathway such
        as regulating cell receptor,purine metabolism,steroid biosynthesis,aminoacyl biosynthesis,etc. CONCLUSIONS:Chaihu shugan
        powder can play a role in the adjunctive treatment of MDD through multiple targets and pathways,which can provide a theoretical
        basis for the follow-up study of its mechanism.
            Δ 基 金 项 目 :国 家 自 然 科 学 基 金 资 助 项 目(No.81760809,  KEYWORDS   Network  pharmacology; Chaihu  shugan
        No.81960858);广 西 自 然 科 学 基 金 面 上 项 目(No.2017GXNS-  powder;Major depressive disorder;Targets;Mechanism
        FAA198294);广西医疗卫生适宜技术开发与推广应用项目(No.
        S2017049);广西中医药大学“岐黄工程”高层次人才团队培育项目
       (No.2018003)                                            重度抑郁症(MDD)是一种具有高发病率、高复发
           *硕士研究生。研究方向:神经内科疾病的临床与基础。电话:                    率、高共病率和高自杀率等特点的情绪性功能障碍疾
        0771-5848502。E-mail:luling931101@163.com             [1]
                                                           病 ,主要临床表现为情绪抑郁、易疲劳、兴趣丧失、精力
           # 通信作者:主任医师,教授,硕士生导师,博士。研究方向:神经
        内科疾病的临床与基础。电话:0771-5848502。E-mail:dlm721226@       减退、注意力下降、决策力受损、反应迟钝等。目前,该
        163.com                                            病的主要治疗方式有药物治疗、物理治疗及心理治疗


        中国药房    2020年第31卷第13期                                             China Pharmacy 2020 Vol. 31 No. 13  ·1569  ·
   34   35   36   37   38   39   40   41   42   43   44